Main Logo
  • About Us
    • Our Philosophy
    • The Industry and Us
  • Our Strategy
    • Our Technology
    • Key Applications
    • Clinical Programs
    • Preclinical Programs
    • Pipeline
    • Our Partnerships
  • Our Team
    • Executive Management
    • Board of Directors
    • Clinical Advisory Board
  • Contact Us
  • Investors

Financial Results

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
    • In The News
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Filings & Financials
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Management Team
  • Investor Resources
    • Contacts
    • Email Alerts
    • FAQs
    • Investor Fact Sheet

  • Financial Info

  • Financial Results
  • Income Statement
  • Balance Sheet
  • Cash Flow

2022

Q3 2022

Quarter Ended Sep 30, 2022
Earnings Release
PDF HTML
Earnings Webcast
Transcript Audio
10-Q Filing
PDF HTML
XBRL
ZIP XLS

Q2 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
Earnings Webcast
Audio
10-Q Filing
PDF HTML
XBRL
ZIP XLS

Q1 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
Earnings Webcast
Transcript Audio
10-Q Filing
PDF HTML
XBRL
ZIP XLS

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF HTML
Earnings Webcast
Transcript Audio
10-K Filing
PDF HTML
XBRL
ZIP XLS

Q3 2021

Quarter Ended Sep 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS

Q2 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Main Logo

Biotech company committed to stemming the prescription drug abuse epidemic.

Our proprietary prodrug technologies are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse.

About Us

  • Our philosophy
  • The Industry and Us

Our strategy

  • Our Technology
  • Key Applications
  • Clinical Programs
  • Preclinical Programs
  • Pipeline
  • Our Partnerships

Our Team

  • Executive Management
  • Board of Directors
  • Clinical Advisory Board

Contact Us

Investors

Follow Ensysce on social media:

  • /company/Ensyscebio
  • @Ensyscebio
  • /Ensyscebio